Game-Changer for Parkinson’s Symptoms

Did you know there’s now a 24/7 infusion treatment for Parkinson’s? The FDA just approved foscarbidopa/foslevodopa as the first continuous subcutaneous delivery system. Unlike regular pills, this pump keeps medication levels steady, which means fewer ups and downs, less "off" time, and even overnight symptom control. Plus, it skips all the stomach issues that come with oral meds. This could seriously level up quality of life for patients and their caregivers! #ParkinsonsDisease #MedicalBreakthrough #HealthTech #Neuroscience #Health